Aperio Group, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$179,000
+73.8%
51,178
+19.7%
0.00%
Q3 2020$103,000
+202.9%
42,767
+128.8%
0.00%
Q2 2020$34,000
-32.0%
18,689
-41.4%
0.00%
Q1 2020$50,000
-35.1%
31,908
-11.8%
0.00%
Q4 2019$77,000
+28.3%
36,184
+13.4%
0.00%
Q3 2019$60,000
+275.0%
31,908
+411.7%
0.00%
Q2 2019$16,000
-81.0%
6,236
-73.1%
0.00%
-100.0%
Q2 2014$84,000
-9.7%
23,181
-3.1%
0.00%0.0%
Q1 2014$93,000
+40.9%
23,933
+3.2%
0.00%0.0%
Q4 2013$66,00023,1920.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders